{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:07:03Z","timestamp":1772114823720,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ygyno.2014.12.020","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T06:19:14Z","timestamp":1425622754000},"page":"472-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Central nervous system metastasis in gynecologic cancer: Symptom management, prognosis and palliative management strategies"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5046","authenticated-orcid":false,"given":"Adam C.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille C.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozer","family":"Algan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sughrue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina N.","family":"Slaughter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2014.12.020_bb0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","article-title":"The management of brain metastases","volume":"29","author":"Patchell","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.020_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2176\/nmc.48.57","article-title":"Treatment and prognosis of brain metastases from gynecological cancers","volume":"48","author":"Ogawa","year":"2008","journal-title":"Neurol Med Chir"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.020_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.11.001","article-title":"Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial)","volume":"128","author":"Nasu","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-009-0057-4","article-title":"The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Ryken","year":"2010","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.12.020_bb0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/IGC.0b013e3181a83301","article-title":"Brain metastases in epithelial ovarian and primary peritoneal carcinoma","volume":"19","author":"Ratner","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.020_bb0030","article-title":"Brain metastases","volume":"18","author":"Lu-Emerson","year":"2012","journal-title":"Continuum Lifelong Learn Neurol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.020_bb0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2013.01.015","article-title":"The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery","volume":"106","author":"Zindler","year":"2013","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.020_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.020_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11060-012-1019-9","article-title":"Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases","volume":"111","author":"Yamamoto","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ygyno.2014.12.020_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2407-13-70","article-title":"Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases","volume":"13","author":"Braccini","year":"2013","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.020_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-012-0916-2","article-title":"Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system","volume":"109","author":"Menendez","year":"2012","journal-title":"J Neurooncol"},{"issue":"9422","key":"10.1016\/j.ygyno.2014.12.020_bb0060","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2007.06.068","article-title":"Stereotactic radiosurgery of the postoperative resection cavity for brain metastases","volume":"70","author":"Soltys","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.ygyno.2014.12.020_bb0070","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.020_bb0075","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.clon.2012.11.002","article-title":"Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?","volume":"25","author":"Langley","year":"2013","journal-title":"Clin Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.12.020_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410330605","article-title":"Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?","volume":"33","author":"Vecht","year":"1993","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-009-0060-9","article-title":"The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Gaspar","year":"2010","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-009-0062-7","article-title":"The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Mehta","year":"2010","journal-title":"J Neurooncol"},{"issue":"12","key":"10.1016\/j.ygyno.2014.12.020_bb0095","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/jnnp-2013-305166","article-title":"Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases","volume":"84","author":"McDuff","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cncr.27504","article-title":"Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer","volume":"119","author":"Monaco","year":"2013","journal-title":"Cancer"},{"issue":"Suppl. 4","key":"10.1016\/j.ygyno.2014.12.020_bb0105","first-page":"iv99","article-title":"QL-08. Quality of life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1\u20133 cerebral metastases of solid tumors","volume":"12","author":"Soffietti","year":"2010","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.020_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11060-009-0073-4","article-title":"The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Linskey","year":"2010","journal-title":"J Neurooncol"},{"issue":"9","key":"10.1016\/j.ygyno.2014.12.020_bb0115","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.26515","article-title":"A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases","volume":"118","author":"Tsao","year":"2012","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2014.12.020_bb0120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.12.020_bb0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.suponc.2010.09.028","article-title":"Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer","volume":"8","author":"Hess","year":"2010","journal-title":"J Support Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.020_bb0130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2011.11.005","article-title":"Cognitive function and quality of life in ovarian cancer","volume":"124","author":"Correa","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T12:27:57Z","timestamp":1537792077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814015753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0090825814015753"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system metastasis in gynecologic cancer: Symptom management, prognosis and palliative management strategies","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}